Works by Mamdani, Hirva

Results: 19

Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLC).

Published in:

Expert Review of Anticancer Therapy, 2025, v. 25, n. 6, p. 711, doi. 10.1080/14737140.2025.2491648

By:

Raez, Luis E.;
Baca, Yasmine;
Ribeiro, Jennifer R.;
Nieva, Jorge J.;
Mamdani, Hirva;
Lopes, Gilberto;
Borghaei, Hossein;
Socinski, Mark;
Wozniak, Antoinette J.;
Vanderwalde, Ari;
Uribe, Carlos Carracedo;
Sumarriva, Daniel;
Khan, Hina;
Liu, Stephen V.;
Nagasaka, Misako

Publication type:

Article

A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2023, v. 24, n. 4, p. 347, doi. 10.1016/j.cllc.2023.03.003

By:

Wei, Cynthia X.;
Mamdani, Hirva;
Gentzler, Ryan;
Kalra, Maitri;
Perkins, Susan;
Althouse, Sandra;
Jalal, Shadia I.

Publication type:

Article

The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 1, p. 52, doi. 10.1016/j.cllc.2021.08.012

By:

Nagasaka, Misako;
Singh, Vijendra;
Baca, Yasmine;
Sukari, Ammar;
Kim, Chul;
Mamdani, Hirva;
Spira, Alexander I.;
Uprety, Dipesh;
Bepler, Gerold;
Kim, Edward S.;
Raez, Luis E.;
Pai, Sachin Gopalkrishna;
Ikpeazu, Chukwuemeka;
Oberley, Matthew;
Feldman, Rebecca;
Xiu, Joanne;
Korn, W. Michael;
Wozniak, Antoinette J.;
Borghaei, Hossein;
Liu, Stephen V.

Publication type:

Article

Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e842, doi. 10.1016/j.cllc.2021.04.004

By:

Fisher, Amanda;
Kim, Seongho;
Farhat, Dina;
Belzer, Kimberly;
Milczuk, MaryAnn;
French, Courtney;
Mamdani, Hirva;
Sukari, Ammar;
Baciewicz, Frank;
Schwartz, Ann G.;
Wozniak, Antoinette;
Nagasaka, Misako

Publication type:

Article

Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1273, doi. 10.1007/s00262-022-03332-z

By:

Parajuli, Prahlad;
Rosati, Rayna;
Mamdani, Hirva;
Wright III, Robert E.;
Hussain, Zahin;
Naeem, Aroma;
Dzinic, Sijana;
Polin, Lisa;
Gavande, Navnath S.;
Ratnam, Manohar

Publication type:

Article

ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.

Published in:

NAR Cancer, 2023, v. 5, n. 4, p. 1, doi. 10.1093/narcan/zcac045

By:

Heyza, Joshua R;
Ekinci, Elmira;
Lindquist, Jacob;
Lei, Wen;
Yunker, Christopher;
Vinothkumar, Vilvanathan;
Rowbotham, Rachelle;
Polin, Lisa;
Snider, Natalie G;
Van Buren, Eric;
Watza, Donovan;
Back, Jessica B;
Chen, Wei;
Mamdani, Hirva;
Schwartz, Ann G;
Turchi, John J;
Bepler, Gerold;
Patrick, Steve M

Publication type:

Article

ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.

Published in:

NAR Cancer, 2023, v. 5, n. 1, p. 1, doi. 10.1093/narcan/zcac045

By:

Heyza, Joshua R.;
Ekinci, Elmira;
Lindquist, Jacob;
Wen Lei;
Yunker, Christopher;
Vinothkumar, Vilvanathan;
Rowbotham, Rachelle;
Polin, Lisa;
Snider, Natalie G.;
Van Buren, Eric;
Watza, Donovan;
Back, Jessica B.;
Wei Chen;
Mamdani, Hirva;
Schwartz, Ann G.;
Turchi, John J.;
Bepler, Gerold;
Patrick, Steve M.

Publication type:

Article

Racial and socioeconomic disparities in survival among patients with metastatic non–small cell lung cancer.

Published in:

JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 10, p. 1697, doi. 10.1093/jnci/djae118

By:

Uprety, Dipesh;
Seaton, Randell;
Hadid, Tarik;
Mamdani, Hirva;
Sukari, Ammar;
Ruterbusch, Julie J;
Schwartz, Ann G

Publication type:

Article

A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinoma.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1435056

By:

Khalid, Ahmed Bilal;
Fountzilas, Christos;
Burney, Heather N.;
Mamdani, Hirva;
Schneider, Bryan P.;
Fausel, Christopher;
Perkins, Susan M.;
Jalal, Shadia

Publication type:

Article

Small-Cell Lung Cancer.

Published in:

Journal of Clinical Outcomes Management, 2018, v. 25, n. 5, p. 229

By:

Mamdani, Hirva;
Jalal, Shadia

Publication type:

Article

A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors.

Published in:

Cancers, 2023, v. 15, n. 9, p. 2553, doi. 10.3390/cancers15092553

By:

Richardson, Gary Edward;
Al-Rajabi, Raed;
Uprety, Dipesh;
Hamid, Anis;
Williamson, Stephen K.;
Baranda, Joaquina;
Mamdani, Hirva;
Lee, Ya-Li;
Nitika;
Li, Li;
Wang, Xingli;
Dong, Xunwei

Publication type:

Article

Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans.

Published in:

JAMA Network Open, 2022, v. 5, n. 10, p. e2237699, doi. 10.1001/jamanetworkopen.2022.37699

By:

Azar, Ibrahim;
Yazdanpanah, Omid;
Jang, Hyejeong;
Austin, Adam;
Kim, Seongho;
Chi, Jie;
Alkassis, Samer;
Saha, Biplab K.;
Chopra, Amit;
Neu, Kristoffer;
Mehdi, Syed;
Mamdani, Hirva

Publication type:

Article

Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration.

Published in:

2015

By:

Mamdani, Hirva;
Jalal, Shadia I;
Hanna, Nasser

Publication type:

journal article

Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration.

Published in:

Current Treatment Options in Oncology, 2015, v. 16, n. 10, p. 1, doi. 10.1007/s11864-015-0364-2

By:

Mamdani, Hirva;
Jalal, Shadia I.;
Hanna, Nasser

Publication type:

Article

Adjuvant Therapy with Durvalumab, a Checkpoint Inhibitor, Shows Promise in Advanced Esophageal Cancer.

Published in:

Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 8, p. 313

By:

Mamdani, Hirva

Publication type:

Article

Association between cannabis use and clinical outcomes in patients with solid malignancies receiving immune checkpoint inhibitors.

Published in:

Therapeutic Advances in Vaccines & Immunotherapy, 2024, v. 12, p. 1, doi. 10.1177/25151355241309095

By:

Hadid, Tarik;
Biedny, Adam;
Mamdani, Hirva;
Azmi, Asfar;
Kim, Seongho;
Jang, Hyejeong;
Uprety, Dipesh;
Al Hallak, Mohammed Najeeb;
Sukari, Ammar

Publication type:

Article

A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.736620

By:

Mamdani, Hirva;
Schneider, Bryan;
Perkins, Susan M.;
Burney, Heather N.;
Kasi, Pashtoon Murtaza;
Abushahin, Laith I.;
Birdas, Thomas;
Kesler, Kenneth;
Watkins, Tracy M.;
Badve, Sunil S.;
Radovich, Milan;
Jalal, Shadia I.

Publication type:

Article

Immunotherapy in Lung Cancer: Current Landscape and Future Directions.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.823618

By:

Mamdani, Hirva;
Matosevic, Sandro;
Khalid, Ahmed Bilal;
Durm, Gregory;
Jalal, Shadia I.

Publication type:

Article

Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer.

Published in:

Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 171, doi. 10.1007/s40262-023-01309-4

By:

Chen, Joseph;
Bearz, Alessandra;
Kim, Dong-Wan;
Mamdani, Hirva;
Bauman, Jessica;
Chiari, Rita;
Ou, Sai-Hong Ignatius;
Solomon, Benjamin J.;
Soo, Ross A.;
Felip, Enriqueta;
Shaw, Alice T.;
Thurm, Holger;
Clancy, Jill S.;
Lee, Kimberly;
O'Gorman, Melissa;
Tanski, Cherie;
Pithavala, Yazdi K.

Publication type:

Article